Dr. David Schwartz, MD

Cardiovascular Disease Plano, TX Male
NPI: 1629065156
Total Payments
$7,253
2024 Payments
$59.81
Companies
36
Transactions
257
Medicare Patients
12,459
Medicare Billing
$507,340

Payment Breakdown by Category

Food & Beverage$4,387 (60.5%)
Consulting$2,860 (39.4%)
Education$5.90 (0.1%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,387 254 60.5%
Consulting Fee $2,860 2 39.4%
Education $5.90 1 0.1%

Top Paying Companies

Company Total Records Latest Year
Takeda Development Center Americas, Inc. $2,060 1 $0 (2017)
ABBVIE INC. $800.00 1 $0 (2022)
Astellas Pharma US Inc $700.50 47 $0 (2023)
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $501.81 16 $0 (2020)
Amgen Inc. $443.96 33 $0 (2023)
Novartis Pharmaceuticals Corporation $431.11 22 $0 (2024)
Amarin Pharma Inc. $353.12 24 $0 (2022)
SANOFI-AVENTIS U.S. LLC $212.82 18 $0 (2024)
Boston Scientific Corporation $165.67 5 $0 (2023)
Merck Sharp & Dohme LLC $152.87 8 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $59.81 3 Novartis Pharmaceuticals Corporation ($41.67)
2023 $368.81 18 Novartis Pharmaceuticals Corporation ($88.79)
2022 $1,748 58 ABBVIE INC. ($800.00)
2021 $368.70 23 Novartis Pharmaceuticals Corporation ($81.06)
2020 $295.05 19 Amgen Inc. ($118.31)
2019 $1,017 61 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($190.69)
2018 $657.48 33 ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) ($238.58)
2017 $2,738 42 Takeda Development Center Americas, Inc. ($2,060)

All Payment Transactions

257 individual payment records from CMS Open Payments — Page 1 of 11

Date Company Product Nature Form Amount Type
11/20/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $23.30 General
Category: Cardiology/Vascular Diseases
02/27/2024 SANOFI-AVENTIS U.S. LLC MULTAQ (Drug) Food and Beverage In-kind items and services $18.14 General
Category: Cardiology/Vascular Diseases
01/29/2024 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $18.37 General
Category: Cardiology/Vascular Diseases
12/13/2023 PFIZER INC. VYNDAQEL (Drug) Food and Beverage In-kind items and services $20.05 General
Category: CARDIOVASCULAR
12/07/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug) Food and Beverage In-kind items and services $24.55 General
Category: Cardiology/Vascular Diseases
12/06/2023 Itamar Medical Inc WatchPATONE (Device) Food and Beverage Cash or cash equivalent $12.00 General
Category: Sleep Apnea testing
12/05/2023 Kiniksa Pharmaceuticals, Ltd. Arcalyst (Drug) Food and Beverage Cash or cash equivalent $16.59 General
Category: Not Applicable
11/28/2023 SANOFI-AVENTIS U.S. LLC MULTAQ (Drug) Food and Beverage In-kind items and services $16.84 General
Category: Cardiology/Vascular Diseases
11/03/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $23.95 General
Category: Diabetes
10/31/2023 Boston Scientific Corporation BodyGuardian (Device) Food and Beverage In-kind items and services $21.93 General
Category: CDS - BG Mini_RM
10/25/2023 Novo Nordisk Inc Ozempic (Drug), Rybelsus Food and Beverage In-kind items and services $22.22 General
Category: Diabetes
10/11/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $20.61 General
Category: Cardiology/Vascular Diseases
09/27/2023 Philips Electronics North America Corporation (6342) Intrasight Integrated (Device) Food and Beverage Cash or cash equivalent $30.54 General
Category: Medical Device
08/02/2023 Novartis Pharmaceuticals Corporation LEQVIO (Drug), ENTRESTO Food and Beverage In-kind items and services $23.41 General
Category: Cardiology/Vascular Diseases
06/14/2023 Novartis Pharmaceuticals Corporation ENTRESTO (Drug), LEQVIO Food and Beverage In-kind items and services $20.22 General
Category: Cardiology/Vascular Diseases
06/06/2023 AstraZeneca Pharmaceuticals LP FARXIGA (Drug) Food and Beverage In-kind items and services $21.52 General
Category: Cardiovascular and Metabolism
05/12/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $17.06 General
Category: Cardiovascular & Metabolism
05/03/2023 Merck Sharp & Dohme LLC VERQUVO (Drug), VERQUVO Food and Beverage In-kind items and services $23.70 General
Category: CARDIOVASCULAR
03/31/2023 SANOFI-AVENTIS U.S. LLC MULTAQ (Drug) Food and Beverage In-kind items and services $15.76 General
Category: Cardiology/Vascular Diseases
03/02/2023 Astellas Pharma US Inc Lexiscan (Drug) Food and Beverage In-kind items and services $21.82 General
Category: Cardiology
01/13/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $16.04 General
Category: Cardiology
12/12/2022 Novartis Pharmaceuticals Corporation ENTRESTO (Drug) Food and Beverage In-kind items and services $24.95 General
Category: CARDIOVASCULAR
12/10/2022 PFIZER INC. ELIQUIS (Drug), COMIRNATY, PAXLOVID Food and Beverage In-kind items and services $28.11 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
11/18/2022 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $18.27 General
Category: DIABETES
11/17/2022 Itamar Medical Inc WatchPAT (Device) Food and Beverage Cash or cash equivalent $19.00 General
Category: Sleep Apnea testing
123…11»

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 2,852 4,700 $418,699 $129,067
2022 21 2,923 4,626 $351,610 $128,487
2021 21 3,270 4,820 $331,914 $128,488
2020 21 3,414 5,310 $348,515 $121,299
Total Patients
12,459
Total Services
19,456
Medicare Billing
$507,340
Procedure Codes
83

All Medicare Procedures & Services

83 procedure records from CMS Medicare Utilization — Page 1 of 4

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 501 764 $182,000 $67,395 37.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 320 423 $71,250 $23,991 33.7%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 606 986 $50,671 $9,666 19.1%
93793 Anticoagulant management of patient taking warfarin Office 2023 304 852 $34,864 $6,706 19.2%
36415 Insertion of needle into vein for collection of blood sample Office 2023 458 737 $12,529 $6,164 49.2%
99442 Telephone medical discussion with physician, 11-20 minutes Office 2023 39 42 $8,916 $2,688 30.1%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Facility 2023 295 358 $10,740 $2,208 20.6%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 31 31 $6,423 $2,076 32.3%
93280 Programming of dual lead pacemaker system Office 2023 24 34 $10,173 $1,735 17.1%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2023 12 12 $4,024 $1,372 34.1%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 12 12 $3,714 $1,238 33.3%
93294 Evaluation of single, dual, multiple lead or leadless pacemaker system, remote up to 90 days Office 2023 20 52 $5,676 $1,049 18.5%
85610 Blood test, clotting time Office 2023 105 238 $6,126 $996.55 16.3%
93296 Evaluation of single, dual, multiple lead or leadless pacemaker system or implantable defibrillator system, remote up to 90 days Office 2023 21 55 $4,616 $826.14 17.9%
93248 Heart rhythm review and interpretation of continous external ekg over 8-15 days Office 2023 14 14 $1,372 $258.20 18.8%
93244 Heart rhythm review, and interpretation of continous external ekg over more than 48 hours up to 7 days Office 2023 13 13 $1,274 $199.71 15.7%
93010 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only Office 2023 26 26 $780.00 $164.14 21.0%
93005 Routine electrocardiogram (ecg) using at least 12 leads with tracing Office 2023 28 28 $1,344 $135.26 10.1%
93246 Heart rhythm recording of continous external ekg over 8-15 days Office 2023 12 12 $1,152 $104.54 9.1%
93242 Heart rhythm recording continous external ekg over more than 48 hours up to 7 days Office 2023 11 11 $1,056 $92.80 8.8%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 381 547 $102,541 $48,796 47.6%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 448 606 $76,952 $36,200 47.0%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 548 789 $39,899 $7,928 19.9%
93793 Anticoagulant management of patient taking warfarin Office 2022 300 863 $28,886 $6,705 23.2%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2022 62 62 $12,370 $4,746 38.4%
1234»

About Dr. David Schwartz, MD

Dr. David Schwartz, MD is a Cardiovascular Disease healthcare provider based in Plano, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/30/2005. The National Provider Identifier (NPI) number assigned to this provider is 1629065156.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Schwartz, MD has received a total of $7,253 in payments from pharmaceutical and medical device companies, with $59.81 received in 2024. These payments were reported across 257 transactions from 36 companies. The most common payment nature is "Food and Beverage" ($4,387).

As a Medicare-enrolled provider, Schwartz has provided services to 12,459 Medicare beneficiaries, totaling 19,456 services with total Medicare billing of $507,340. Data is available for 4 years (2020–2023), covering 83 distinct procedure/service records.

Practice Information

  • Specialty Cardiovascular Disease
  • Location Plano, TX
  • Active Since 09/30/2005
  • Last Updated 02/17/2023
  • Taxonomy Code 207RC0000X
  • Entity Type Individual
  • NPI Number 1629065156

Products in Payments

  • Entyvio (Biological) $2,060
  • RINVOQ (Biological) $800.00
  • LifeVest (Device) $501.81
  • LEXISCAN (Drug) $471.34
  • Vascepa (Drug) $353.12
  • ENTRESTO (Drug) $341.48
  • Repatha (Biological) $253.73
  • Lexiscan (Drug) $229.16
  • Corlanor (Drug) $190.23
  • PRALUENT (Drug) $135.61
  • PRALUENT (Biological) $123.35
  • XARELTO (Drug) $122.80
  • VERQUVO (Drug) $121.62
  • ELIQUIS (Drug) $112.15
  • LEQVIO (Drug) $89.63
  • MULTAQ (Drug) $77.21
  • WATCHMAN (Device) $72.31
  • RESOLUTION CLIP (Device) $71.43
  • NEXLETOL (Drug) $70.28
  • PRALUENT ALIROCUMAB INJECTION (Biological) $66.23

Explore

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Cardiovascular Disease Doctors in Plano

Srinivasa Potluri, Md, MD

Cardiovascular Disease — Payments: $783,265

Cardiovascular Disease $783,265

Dr. David Brown, M.d, M.D

Cardiovascular Disease — Payments: $256,750

Cardiovascular Disease $256,750

David Rawitscher, Md, MD

Cardiovascular Disease — Payments: $244,805

Cardiovascular Disease $244,805

Sahil Bakshi, Do, DO

Cardiovascular Disease — Payments: $193,440

Cardiovascular Disease $193,440

Mordecai Klein, Md, MD

Cardiovascular Disease — Payments: $162,433

Cardiovascular Disease $162,433

Dr. Vijay Ramanath, M.d, M.D

Cardiovascular Disease — Payments: $123,142

Cardiovascular Disease $123,142